Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The purpose of the study is to find some biomarkers to predict the the adverse events of Immune Checkpoint Inhibitors monotherapy or plus platinum based chemotherapy in lung cancer.
Epistemonikos ID: e0bfdfec3f952d9db0ad6889d3d4c2dad3064e40
First added on: May 09, 2024